Come up with a name for your new list and we'll add to it:
SARcode Biosciences raised a round of funding on January 10, 2009. Investors include
Qualifying Therapeutic Discovery Project.
SARcode is a private, San Francisco based biotechnology company focused on the development of small molecule LFA-1 antagonists to treat inflammatory diseases. Targets include topical therapies for T-c…